Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2006;32:110-113; doi:10.1136/jme.2005.013599
Copyright © 2006 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

NEUROETHICS

Cosmetic neurology

The promise and predicament of cosmetic neurology

A Chatterjee

Correspondence to:
Correspondence to:
Anjan Chatterjee
Department of Neurology and the Center for Cognitive Neuroscience, The University of Pennsylvania, 3 West Gates, 3400 Spruce Street, Philadelphia, PA 19147, USA; anjan@mail.med.upenn.edu

Original version received 13 July 2005

Accepted 14 July 2005


Advances in cognitive neuroscience make cosmetic neurology in some form inevitable and will give rise to extremely difficult ethical issues

Keywords: cognitive neuroscience; neuropharmacology; brain disorders; cosmetic neurology

The first 150 words of the full text of this article appear below.

Consider the following hypothetical case study. A well heeled executive walks into my cognitive neurology clinic because he is concerned that he is becoming forgetful. It turns out that he is going through a difficult divorce and my clinical impression is that his memory problems stem from the stress he is experiencing. I place him on a selective seratonin reuptake inhibitor, sertraline, and in a few weeks he feels better. Around this time his 13 year old daughter has difficulty at school and is diagnosed by the school psychologist as having attention deficit disorder. I place her on adderall, a stimulant combination drug, which seems to help with her behaviour in school. My patient then comes to me because he is experiencing the "tip of the tongue" phenomena more frequently. He is concerned that his word finding difficulty interferes with his ability to function in high level meetings. . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Chatterjee, A. (2009). Is it acceptable for people to take methylphenidate to enhance performance? No. BMJ 338: b1956-b1956 [Full Text]  
  • Appel, J M (2008). When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. J. Med. Ethics 34: 616-618 [Abstract] [Full Text]  
  • Schermer, M (2008). On the argument that enhancement is "cheating". J. Med. Ethics 34: 85-88 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.